PHOTREXA VISCOUS IN DEXTRAN 20% Drug Patent Profile
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
When do Photrexa Viscous In Dextran 20% patents expire, and what generic alternatives are available?
Photrexa Viscous In Dextran 20% is a drug marketed by Glaukos and is included in one NDA.
The generic ingredient in PHOTREXA VISCOUS IN DEXTRAN 20% is riboflavin 5'-phosphate sodium. There are ten drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the riboflavin 5'-phosphate sodium profile page.
Summary for PHOTREXA VISCOUS IN DEXTRAN 20%
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 30 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | PHOTREXA VISCOUS IN DEXTRAN 20% at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for PHOTREXA VISCOUS IN DEXTRAN 20%
US Patents and Regulatory Information for PHOTREXA VISCOUS IN DEXTRAN 20%
PHOTREXA VISCOUS IN DEXTRAN 20% is protected by zero US patents and two FDA Regulatory Exclusivities.
FDA Regulatory Exclusivity protecting PHOTREXA VISCOUS IN DEXTRAN 20%
TREATMENT OF CORNEAL ECTASIA FOLLOWING REFRACTIVE SURGERY
Exclusivity Expiration: ⤷ Try a Trial
TREATMENT OF PROGRESSIVE KERATOCONUS
Exclusivity Expiration: ⤷ Try a Trial
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Glaukos | PHOTREXA VISCOUS IN DEXTRAN 20% | riboflavin 5'-phosphate sodium | SOLUTION/DROPS;OPHTHALMIC | 203324-002 | Apr 15, 2016 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Glaukos | PHOTREXA VISCOUS IN DEXTRAN 20% | riboflavin 5'-phosphate sodium | SOLUTION/DROPS;OPHTHALMIC | 203324-002 | Apr 15, 2016 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
